Associate Program Director, Pediatric Neuro-oncology Fellowship

Conditions Treated:

Kevin C. De Braganca, MD

About Me

I am a pediatric neurologist who treats children and young adults with primary pediatric brain tumors such as medulloblastoma, ependymoma, and high- and low-grade gliomas (astrocytomas). I also treat patients with neurologic symptoms such as headaches, seizures, and neuropathic pain or weakness due to any cancer and/or cancer therapy.

Read more

I direct clinical trials at Memorial Sloan Kettering that are helping to advance the treatment of brain tumors. My particular area of interest is young adult patients with medulloblastoma or ependymoma. These tumors are rarely seen in this population, and therefore experience managing them is limited. At our Center, we have a base of experience to draw from and are working on the optimal treatment for patients with these rare cancers. Part of my professional responsibilities is also to mentor and teach our fellows, residents, and medical students to help further the care of patients with brain tumors.

Here at Memorial Sloan Kettering, we work as a team to provide patients and their families with coordinated care and support. This multifaceted approach to treating patients with brain tumors is what drew me to this field. The relationships that I develop with my patients and their families continue to fuel my motivation.

  • Clinical Expertise: Pediatric Neuro-Oncology; Pediatric Neurology
  • Languages Spoken: English
  • Education: MD, University of Medicine and Dentistry of New Jersey
  • Residencies: Pediatrics - Columbia University
  • Fellowships: Neurology - Children's National Medical Center; Neuro-Oncology - Memorial Sloan-Kettering Cancer Center
  • Board Certifications: Pediatrics; Neurology, with special certification in Child Neurology

New Patient Appointments

Making an appointment

Call 866-886-9807


Visit PubMed for a full listing of Kevin C. De Braganca’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more